> Home > Newsroom > Events > Imaging Hallmarks of Cancer 2017

Symposium on Imaging Hallmarks of Cancer

Champalimaud Foundation in partnership with ESOR
Champalimaud Centre for the Unknown, Oct 26/27, 2017

ESOR Symposium on Imaging Hallmarks of Cancer

In Partnership with the Champalimaud Foundation

October 26-27, 2017 • Lisbon/Portugal

Host Organiser: Celso Matos

Register online


To complete your registration, please fill in the registration form and enter your credit card payment information (VISA, MasterCard or American Express). Eventbrite - the website event management service used - is PCI Compliant ensuring that all online transactions are secure.

The course is designed for radiologists and all those professionals interested in acquiring knowledge on cutting-edge methods to diagnose, to treat and to manage cancer patients. A renowned multidisciplinary faculty will provide the delegates with a blend of basic science and the most recent developments in computational, functional, and molecular imaging techniques as well as in the rapidly evolving field of Interventional Oncology.

• to learn how to use novel imaging methods to interrogate cancer biology and physiology
• to envision how translational research may help developing imaging research
• to become familiar with and understand the added value of image-guided intervention in cancer care


Thursday, October 26, 2017

17:00 - 17:30 Registration

17:30 - 17:50 Welcome and introduction

L. Beleza, Lisbon/PT - President of the Champalimaud Foundation

N. Gourtsoyiannis, Athens/GR - Scientific Educational Director of ESOR

C. Matos, Lisbon/PT - Host organiser

18:00 - 18:30 Keynote lecture

Chair: C. Matos, Lisbon/PT

Research in medical imaging in the digital era - G. Krestin, Rotterdam/NL

18:30 - 19:00 Interlude

Scrofulous Sogolon - Scanning the Sunjata Epic - M. Ghyssels, Brussels/BE

Friday, October 27, 2017

09:00 - 10:45 Computational imaging

Chair: C. Matos, Lisbon/PT

Introductory remarks. Open questions - C. Matos, Lisbon/PT

MR imaging biomarkers in cancer - N. Papanikolaou, Lisbon/PT

Texture analysis in medical images: applications in cancer - A. Alberich-Bayarri, Valencia/ES

Radiomics - the promise of imaging for precision medicine - S. Carvalho, Cambridge/UK

Panel discussion: will computational imaging maximise radiology’s role in cancer care?

10:45 - 11:15 Coffee break

11:15 - 13:00 New insights from basic science

Chair: L. Marti-Bonmati, Valencia/ES

Introductory remarks. Open questions - L. Marti-Bonmati, Valencia/ES

Cancer and immune reaction - M. Ferreira, Lisbon/PT

Identification and targeting of cancer metastatic niches - B. Costa Da Silva, Lisbon/PT

Single cell imaging of tumour heterogeneity and response to therapy in human-zebrafish xenografts - R. Fior, Lisbon/PT

Panel discussion: challenges in translational research

13:00 - 14:00 Lunch break

14:00 - 15:45 Molecular imaging

Chair: D. Costa, Lisbon/PT

Introductory remarks. Open questions - D. Costa, Lisbon/PT

Radiomics - new markers in PET-CT - N. Schaefer, Lausanne/CH

Multiparametric MR and PET imaging of intratumoural biological heterogeneity - A.J. Beer, Ulm/DE

Diagnostic molecular pathology: reading a patient’s tissue in the 21th century - A. Beltran, Lisbon/PT

Panel discussion: how to incorporate molecular imaging into the clinics?

15:45 - 16:15 Coffee break

16:15 - 18:00 Interventional oncology

Chair: F. Caseiro Alves, Coimbra/PT

Introductory remarks. Open questions - F. Caseiro Alves, Coimbra/PT

Percutaneous image-guided cryoablation: current applications in cancer - A. Gangi, Strasbourg/FR

Local ablation in oligometastatic disease - A. Gillams, London/UK

Image guided therapy in HCC: what is new? - J.F.H. Geschwind, New Heaven/US

Panel discussion: the pros and cons of image-guided intervention in oncology